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BeBACKGROUND Chronic total occlusion (CTO) is common, being reported in 18% to 30% of patients undergoing
coronary angiography. Percutaneous coronary intervention (PCI) is usually performed to relieve anginal symptoms, but
data are emerging to suggest that there may also be a mortality beneﬁt.
OBJECTIVES This study aimed to compare outcomes of patients with successful versus unsuccessful PCI to a CTO.
METHODS We analyzed the U.K. Central Cardiac Audit Database for all CTO PCI cases carried out in England and Wales
between January 1, 2005, and December 31, 2009. Vital status in September 2010 was obtained from the Medical
Research Information Service.
RESULTS A total of 13,443 patients (78.8% male) had a mean age of 63.5 years and underwent 14,439 CTO procedures.
CTO PCI was successful in 10,199 cases (70.6%). During follow-up of 2.65 years (interquartile range: 1.59 to 3.83 years),
successful PCI of at least 1 CTO was associated with improved survival (hazard ratio [HR]: 0.72; 95% CI: 0.62 to 0.83;
p < 0.001). Complete revascularization was associated with improved survival compared with partial revascularization
(HR: 0.70; 95% CI: 0.56 to 0.87; p ¼ 0.002) or failed revascularization (HR: 0.61; 95% CI: 0.50 to 0.74; p < 0.001).
CONCLUSIONS Successful CTO PCI was associated with improved long-term survival. The improvement was greatest in
patients when complete revascularization was achieved. The identity of the successfully treated occluded vessel was not
associated with differences in outcome. (J Am Coll Cardiol 2014;64:235–43) © 2014 by the American College of
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LAD = left anterior descending
artery
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236A chronic total occlusion (CTO) isdeﬁned as a complete coronaryarterial obstruction with Throm-
bolysis In Myocardial Infarction (TIMI) ﬂow
grade of 0 for longer than 3 months (1).
CTOs have been identiﬁed in up to 20% of
all patients referred for diagnostic angiog-
raphy (2). CTO procedural success rates are
low at 60% to 70%, compared with non-
CTO percutaneous coronary intervention
(PCI) success rates of 98% (2,3). Patients
with a CTO are often managed conserva-
tively or surgically rather than with PCI (4).
Successful CTO intervention is associated
with symptomatic relief of angina, lower
rates of subsequent myocardial infarction(MI) and coronary artery bypass graft (CABG), and
survival improvement (5,6).SEE PAGE 244There is some evidence that complete revasculari-
zation by PCI is associated with a survival advantage
when compared with incomplete revascularization
(7). Successful CTO PCI of the left anterior descending
artery (LAD) was also associated with improvement,
whereas successful intervention on the left circum-
ﬂex artery (LCx) or right coronary artery (RCA) was
not. To address these issues, we analyzed the inci-
dence and outcomes of CTO PCI in contemporary
coronary angioplasty practice in the United Kingdom.
We assessed mortality related to completeness of
revascularization and to the location of the occluded
vessel.
METHODS
The British Cardiovascular Intervention Society
(BCIS) Central Cardiac Audit Database captures
details of all interventional cardiology procedures
carried out in England and Wales, using a data set
managed by the National Institute for Cardiovascular
Outcomes Research. We carried out an analysis of all
CTO interventions carried out in England and Wales
between January 1, 2005, and December 31, 2009.
Data on patient mortality were obtained by linkingk has received lecture fees from Medtronic, Eli Lilly/Daiichi Sank
Medtronic. All other authors have reported that they have no re
is manuscript’s audio summary by JACC Editor-in-Chief Dr. Vale
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received January 6, 2014; revised manuscript received March 12with the Ofﬁce for National Statistics by the Medical
Research Information Service (MRIS).
STUDY DEFINITIONS.
 A CTO was deﬁned as a complete occlusion with
TIMI ﬂow grade 0 antegrade through the affected
segment of >3 months’ duration in the opinion of
the operator based on clinical features, angio-
graphic features, and/or previous imaging.
 Procedural success was deﬁned as <50% residual
stenosis with TIMI ﬂow grade 3 antegrade. Al-
though procedural success is often quoted using
a <30% cutoff, the BCIS database does not further
differentiate patients with a <50% stenosis.
 Complete revascularization was deﬁned as suc-
cessful PCI to the target CTO and post-procedural
obstruction of <50% in all major epicardial coro-
nary arteries.
 Partial revascularization was deﬁned as successful
PCI to the target CTO but with residual obstruction
of >50% in $1 other vessels.
 Failure was deﬁned as failure to cross the occlusion
or reduce obstruction to less than 50% in the
target CTO.
STATISTICS. The primary analysis compared out-
comes according to successful versus unsuccessful
intervention on the target CTO(s). Additional
analysis considered differences in mortality related to
completeness of revascularization. Univariate and
multivariate models were developed to assess the
association between success of the PCI and subse-
quent mortality. Candidate variables included base-
line demographics and other cardiovascular risk
factors. A Cox proportional hazards model was used
to identify those variables that were independent
predictors of mortality. For assessment of the impact
of revascularization success on subsequent mortality
and allowing for patients undergoing several pro-
cedures, success of revascularization was entered as a
time-updated covariate. For these patients, follow-up
time was split into periods ending either in a further
procedure, censoring, or death. Variables were
included if they were independent predictors (with
p < 0.01) or confounded the relationship between
success of revascularization and mortality. For the
other variables included in the models, unknownyo, and Abbott Vascular; and has served on advisory
lationships relevant to the contents of this paper to
ntin Fuster.
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TABLE 1 Success and Failure of CTO Intervention
Factor
No. of Patients
(First Procedure)
(n ¼ 13,443)
Total No. of
Procedures
(n ¼ 14,439)
No. of
Failures
(n ¼ 4,240)
No. of
Successes
(n ¼ 10,199) p Value
Sex
Male 10,456 11,284 3,370 (29.9%) 7,914 (70.1%) 0.030
Female 2,817 2,983 826 (27.7%) 2,157 (72.3%)
Age, yrs
<50 1,472 1,581 423 (26.8%) 1,158 (73.2%) 0.009*
50–<60 3,497 3,751 1,092 (29.1%) 2,659 (70.9%)
60–<70 4,532 4,898 1,451 (29.6%) 3,447 (70.4%)
70–<80 3,224 3,451 1,039 (30.1%) 2,412 (69.9%)
$80 714 754 232 (30.8%) 522 (69.2%)
Angina pre-PCI
None 572 598 191 (31.9%) 407 (68.1%) <0.001*
Grade 1 1,525 1,629 510 (31.3%) 1,119 (68.7%)
Grade 2 5,580 6,049 1,864 (30.8%) 4,185 (69.2%)
Grade 3 4,114 4,419 1,194 (27.0%) 3,225 (73.0%)
Grade 4 303 320 80 (25.0%) 240 (75.0%)
NYHA pre-PCI
Class I 3,878 4,179 1,246 (29.8%) 2,933 (70.2%) 0.058*
Class II 5,384 5,829 1,765 (30.3%) 4,064 (69.7%)
Class III 1,950 2,092 600 (28.7%) 1,492 (71.3%)
Class IV 303 136 31 (22.8%) 105 (77.2%)
Previous MI
No 6,858 7,328 2,045 (27.9%) 5,283 (72.1%) <0.001
Yes 4,946 5,401 1,754 (32.5%) 3,647 (67.5%)
Previous CABG
No 11,329 12,126 2,481 (20.5%) 8,645 (79.5%) <0.001
Yes 1,385 1,555 571 (36.7%) 984 (63.3%)
Previous PCI
No 9,797 10,028 2,746 (27.4%) 7,282 (72.6%) <0.001
Yes 2,969 3,706 1,311 (35.4%) 2,395 (64.6%)
Diabetes
None 10,165 10,890 3,167 (29.1%) 7,723 (70.9%)
Diet-controlled 545 593 199 (33.6%) 394 (66.4%) 0.034
Tablet-controlled 1,309 1,442 427 (29.6%) 1,015 (70.4%) 0.96
Insulin-dependent 577 625 220 (35.2%) 405 (64.8%) 0.005
Smoking status
Never 3,907 4,157 1,116 (26.8%) 3,041 (73.2%) <0.001*
Ex-smoker 5,761 6,267 1,921 (30.7%) 4,346 (69.3%)
Smoker 1,686 1,809 612 (33.8%) 1,197 (66.2%)
Family history of CAD
No 5,044 5,391 1,572 (29.2%) 3,819 (70.8%) 0.65
Yes 6,031 6,539 1,953 (29.9%) 4,586 (70.1%)
Hypercholesterolemia
No 4,360 4,652 1,310 (28.2%) 3,342 (71.8%) 0.042
Yes 7,971 8,609 2,629 (30.5%) 5,980 (69.5%)
Hypertension
No 5,494 5,871 1,698 (28.9%) 4,173 (71.1%) 0.41
Yes 6,837 7,390 2,241 (30.3%) 5,149 (69.7%)
Left ventricular EF
>50% 5,437 5,831 1,661 (28.5%) 4,170 (71.5%) 0.12*
30%–50% 1,354 1,464 491 (33.5%) 973 (66.5%)
<30% 406 433 121 (27.9%) 312 (72.1%)
Peripheral vascular disease
No 11,704 12,585 3,685 (29.3%) 8,900 (70.7%) <0.001
Yes 627 676 254 (37.6%) 422 (62.4%)
Continued on the next page
J A C C V O L . 6 4 , N O . 3 , 2 0 1 4 George et al.
J U L Y 2 2 , 2 0 1 4 : 2 3 5 – 4 3 Follow-Up of CTO Angioplasty
237
TABLE 1 Continued
Factor
No. of Patients
(First Procedure)
(n ¼ 13,443)
Total No. of
Procedures
(n ¼ 14,439)
No. of
Failures
(n ¼ 4,240)
No. of
Successes
(n ¼ 10,199) p Value
Cerebrovascular disease
No 11,973 12,876 3,797 (29.5%) 9,079 (70.5%) 0.001
Yes 358 385 142 (36.9%) 243 (63.1%)
Renal disease
None 12,097 13,030 3,866 (29.7%) 9,164 (70.3%)
Transplant 14 15 3 (20.0%) 12 (80.0%) 0.38
Creatinine >200 152 163 54 (33.1%) 109 (66.9%) 0.51
Acute failure 6 6 3 (50.0%) 3 (50.0%) 0.46
Chronic failure 73 79 25 (31.6%) 54 (68.4%) 0.91
Values are n or n (%). *Trend test across groups.
CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; CTO ¼ chronic total occlusion; EF ¼ ejection fraction; MI ¼ myocardial infarction; NYHA ¼ New York
Heart Association; PCI ¼ percutaneous coronary intervention.
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238values were considered as absent or in the lowest-
risk category as appropriate, although a sensitivity
analysis including missing values as a separate
category had no impact on the results of the associ-
ation between success of revascularization and
mortality. For descriptive purposes, Kaplan-MeierTABLE 2 Associations With CTO Failure After
Multivariate Analysis
Factor Odds Ratio 95% CI p Value
Age per 10-yr increase 1.06 1.02–1.10 0.002
Sex
Male 1.00
Female 0.92 0.83–1.01 0.03
Angina (CCS class)
0 1.00 <0.001*
1 1.05 0.90–1.22
2 0.98 0.87–1.10
3 0.75 0.66–0.85
4 0.75 0.56–1.00
Smoker
Never 1.00 <0.001*
Ex 1.12 1.03–1.22
Current 1.40 1.24–1.59
BMI per 5 kg/m2 increase 1.10 1.04–1.16 0.001
Previous CABG
No 1.00 <0.001
Yes 1.47 1.30–1.65
Peripheral vascular disease
No 1.00 <0.001
Yes 1.40 1.08–1.26
Previous MI
No 1.00 <0.001
Yes 1.17 1.06–1.24
*Trend test across groups.
BMI ¼ body mass index; CCS ¼ Canadian Cardiovascular Society; other
abbreviations as in Table 1.curves were used to demonstrate survival after
each separate procedure, according to success of
revascularization. For these curves, follow-up was
censored at the time of the subsequent PCI or, for
the last procedure, the end of follow-up (or death).
Other analyses also considered the associations
between baseline risk factors and success of revas-
cularization using logistic regression with generalized
estimating equations to allow for repeated pro-
cedures in some patients. A further sensitivity anal-
ysis using propensity score matching was calculated
using logistic regression with generalized estimating
equations with success of the revascularization as the
outcome (8).
RESULTS
PATIENT POPULATION. During the 5-year period,
15,492 CTO procedures were performed in stable
elective patients. Data on success of revasculariza-
tion was unavailable for 806 procedures (5.2%);
mortality data from the MRIS was unavailable for
247 patients (1.6%). There were 14,439 procedures
(on 13,443 patients) with complete information on
both the success of the CTO attempt and patient
vital status. Of those, 12,542 patients (93.3%) had a
single CTO procedure, 816 patients (6.07%) had 2
CTO procedures, 75 patients (0.56%) had 3 CTO
procedures, and 10 patients (0.07%) had 4 CTO
procedures.
PATIENT DEMOGRAPHICS. The demographics of the
13,443 patients in the study cohort are detailed in
Table 1. The average age of the patients was 63.5
years, and 78.8% were male.
PROCEDURAL SUCCESS. Procedural success was
achieved in 70.6% of procedures (n ¼ 10,199). In these
10%
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No CTO PCI success
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239cases, 8,385 (82.2%) received a drug-eluting stent,
1,394 (13.7%) received a bare-metal stent, 398 (3.9%)
had no stents, and data were missing for 22 patients
(0.2%). Table 1 shows the univariate associations with
CTO procedural success. After multivariate analysis,
increasing age, angina, smoking status, increasing
body mass index, previous CABG, peripheral vascular
disease, and previous MI all were associated with
failure of CTO intervention (Table 2). There were 751
deaths (5.6%) among the 13,443 patients (20.4 per
1,000 person-years of follow-up). Figure 1 shows
mortality according to success or failure of the CTO0
4240
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FIGURE 1 Kaplan-Meier Curve Showing Differences in Mortality Between Those
Procedures With Successful and Failed CTO Interventions
Successful intervention was associated with a decrease in mortality (adjusted hazard ratio:
0.72; 95% conﬁdence interval: 0.62 to 0.83; p < 0.001). CTO ¼ chronic total occlusion;
PCI ¼ percutaneous coronary intervention.
TABLE 3 Associations With Mortality After Multivariate
Analysis
Factor
Deaths
(n ¼ 751)
Hazard
Ratio 95% CI p Value
CTO revascularization
Success 492 0.72 0.62–0.83 <0.001
Failure 259 1.00
Age, yrs
<50 34 1.00 <0.001*
50–<60 83 1.02 0.68–1.52
60–<70 234 2.28 1.59–3.28
70–<80 270 3.94 2.74–5.66
$80 130 9.28 6.31–13.67
Angina
None 47 1.00 <0.001*
1 68 0.53 0.40–0.72
2 292 0.61 0.49–0.76
3 229 0.59 0.47–0.74
4 19 0.50 0.30–0.84
NYHA functional class
I 164 1.00 <0.001*
II 286 1.16 0.97–1.39
III 149 1.40 1.13–1.75
IV 18 2.45 1.46–4.12
Diabetes
None 515 1.00
Diet only 37 1.06 0.76–1.48 0.72
Oral agents 79 1.13 0.89–1.43 0.31
Insulin 53 1.84 1.38–2.45 <0.001
Smoker
Never 180 1.00 <0.001*
Ex 350 1.28 1.09–1.49
Current 84 1.67 1.30–2.14
Left ventricular EF
>50% 484 1.00 <0.001*
30%–50% 152 1.27 1.02–1.58
<30% 47 2.24 1.68–2.97
Renal disease
No 605 1.00 <0.001
Any 52 3.05 2.26–4.13
*Trend test across groups. For age, the hazard ratio for a 10-year increase in age
was 2.01 (95% CI: 1.86 to 2.18).
Abbreviations as in Table 1.procedure during a median follow-up of 2.65 years
(interquartile range: 1.59 to 3.83 years).
Successful revascularization of at least 1 CTO was
associated with decreased mortality (unadjusted
hazard ratio [HR]: 0.67; 95% CI: 0.58 to 0.78; adjusted
HR: 0.72; 95% CI, 0.62 to 0.83; p < 0.001). The results
and interpretation from the propensity score match-
ing conﬁrmed the above results (HR: 0.66; 95% CI:
0.54 to 0.80). According to the multivariate analysis,
failed revascularization, increasing age, heart failure,
insulin-dependent diabetes, smoking, and renal dis-
ease were associated with increased mortality
(Table 3, Fig. 2).
In 20.1% of successful procedures, there were
incomplete data for the percentage stenosis of each
epicardial vessel. Data were available on 11,543 pro-
cedures for completeness of revascularization, with
595 deaths. Reduced mortality was observed with
increasing completeness of revascularization (trend
test, p < 0.001). Mortality was lower in patients with
complete revascularization of all epicardial vessels
compared with those with partial revascularization
(adjusted HR: 0.70; 95% CI: 0.56 to 0.87; p ¼ 0.002)
and with those with failed CTO revascularization
(adjusted HR: 0.61; 95% CI: 0.50 to 0.74; p < 0.001)
(Central Illustration).
Of the 14,439 procedures, single CTO PCIs were
attempted in 10,957 (75.9%). Of these, 3,213 pro-
cedures (29.3%) were to the LAD (successful in
0.1
Failed revascularization
No angina Pre-PCI
Angina pre-PCI Grade 1 (0.53, 0.40-0.72)
Angina pre-PCI Grade 2 (0.61, 0.49-0.76)
Angina pre-PCI Grade 3 (0.59, 0.47-0.74)
Angina pre-PCI Grade 4 (0.50, 0.30-0.84)
NYHA pre PCI I
No DM
DM - diet only (1.06, 0.76-1.48)
DM - oral agents (1.13, 0.89-1.43)
DM - insulin (1.84, 1.38-2.45)
Never smoked
LV ejection fractions >50%
LV ejection fraction 30-50% (1.27, 1.02-1.58)
LV ejection fraction <30% (2.24, 1.68-2.97)
No renal disease
Renal disease (3.05, 2.26-4.13)
Ex-smoker (1.28, 1.09-1.49)
Current smoker (1.67, 1.30-2.14)
NYHA pre PCI II (1.16, 0.97-1.39)
NYHA pre PCI III (1.40, 1.13-1.75)
NYHA pre PCI IV (2.45, 1.46-4.12)
Age <50
Age 80+ (9.28, 6.31-13.67)
Age 50-<60 (1.02, 0.68-1.52)
Age 60-<70 (2.28, 1.59-3.28)
Age 70-<80 (3.94, 2.74-5.66)
Successful revascularization (0.72,0.62-0.83)
1 10
Hazard Ratio
100
FIGURE 2 Multivariate Predictors of Death After Attempted CTO Revascularization
Failed revascularization, increasing age, heart failure, insulin-dependent diabetes mellitus (DM), smoking, and renal disease were associated
with increased mortality. The squares and bars represent adjusted hazard ratios and 95% conﬁdence interval, respectively. LV ¼ left
ventricular; NYHA ¼ New York Heart Association; other abbreviations as in Figure 1.
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24072.6%); 1,947 (17.8%) to the LCx (successful in 73.3%);
and 5,446 (49.7%) to the RCA (successful in 64.0%).
Compared with the RCA, revascularization was more
likely to be successful in the LCx (adjusted odds ratio
for failure: 0.61; 95% CI: 0.52 to 0.72; p < 0.001) or
LAD (adjusted odds ratio: 0.73; 95% CI: 0.64 to 0.84;
p < 0.001). There was no difference in survival
between patients with occluded LAD and occluded
RCA (adjusted HR: 0.99; 95% CI: 0.80 to 1.21; p ¼ 0.91)
(Fig. 3). There was a suggestion that occlusion of the
LCx was associated with an increase in mortality
compared with the RCA (adjusted HR: 1.25; 95% CI:
1.00 to 1.58; p ¼ 0.052). Successfully opening a major
target vessel was associated with reduced mortality
after multivariable analysis (LAD: HR: 0.69; 95% CI:
0.49 to 0.97; p ¼ 0.033; LCx: HR: 0.56; 95% CI: 0.38to 0.82; p ¼ 0.003; RCA: HR: 0.73; 95% CI: 0.57
to 0.95; p ¼ 0.017). The association of success
with revascularization on mortality did not differ
according to the epicardial vessel treated (interaction
p ¼ 0.52) (Fig. 4).
Complications included in-hospital death (0.25%),
Q-wave MI (0.42%), cerebrovascular accident (0.06%),
cardiac tamponade (0.15%), coronary artery dissec-
tion (4.69%), coronary artery perforation (1.26%),
ventricular ﬁbrillation (0.31%), and emergency CABG
(0.10%).
DISCUSSION
The main ﬁnding from this large prospective, obser-
vational, multicenter registry of consecutive CTO
CENTRAL ILLUSTRATION Outcomes for Complete, Partial, and Failed
CTO Revascularization
Kaplan-Meier curve showing mortality in procedures with successful, partially successful,
and failed chronic total occlusion (CTO) intervention. Adjusted hazard ratios for complete
CTO revascularization are 0.70 (95% conﬁdence interval: 0.56 to 0.87) versus partial
revascularization and 0.61 (95% conﬁdence interval: 0.50 to 0.74) versus failed
revascularization.
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241recanalizations across all U.K. PCI centers between
2005 and 2009 is the strong association between
successful CTO revascularization and improved sur-
vival over a median follow-up of 2.65 years (inter-
quartile range: 1.59 to 3.83 years). This is important
because a recent large observational study found an
association between successful CTO intervention and
fewer cardiovascular deaths but did not demonstrate
an increase in absolute survival (9). The improvement
in survival remained after multivariate analysis,
suggesting that it is independent of measurable con-
founding factors. The survival outcome of successful
revascularization did not vary between the different
epicardial vessels.
Increasing age, diabetes, heart failure, smoking,
and renal disease were conﬁrmed as factors associ-
ated with increased all-cause mortality, whereas
increasing age, smoking history, increasing body
mass index, previous CABG, peripheral vascular
disease, and previous MI were found on multivar-
iate analysis to be associated with failure of
CTO revascularization. Although complication rates
were low, a failed procedure is different than
medical therapy, and there are currently no large
randomized controlled studies that have looked
at differences in clinical outcome between CTO
PCI versus optimal medical management. The
EuroCTO study, which will address this question,
started recruiting in Europe during late 2012.
Results from previous cohort studies comparing
successful versus failed CTO PCIs have been in-
consistent with regard to potential survival beneﬁt
(5,6,10,11).
With regard to CTO PCI procedural success, the rate
in our U.K. series was 70.6%, which is consistent with
data from other series (2). When reasons for failure of
CTO revascularization were analyzed, factors such as
severity of calciﬁcation (more frequent in older
patients) and tortuosity (often extreme after the
distortion of the native vessel post-CABG) may be
important. Unfortunately, the BCIS data set does not
contain a direct record of these factors or of other
anatomic predictors, such as occlusion length and
absence of a stump, and so these cannot be included
as potential predictors.
Serious complications, including death, MI, cere-
brovascular accident, and cardiac tamponade, were
noted at low rates, consistent with previously pub-
lished series.
STUDY LIMITATIONS. Registries suffer from a num-
ber of limitations. This is an observational study;
therefore, analyses were retrospectively performed
on data entered prospectively, which could introducepotential bias. Also, the accuracy and completeness
of patient characteristics, procedural techniques,
and outcomes were reviewed by the PCI unit’s
local audit and governance processes but were not
independently assessed by external observers. Our
data also do not include information on the exact
medical treatment that different patients were
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FIGURE 3 Kaplan-Meier Curve Showing Mortality by CTO Vessel Among
Procedures With a Single CTO Targeted
There was no difference in survival between patients with occluded left anterior
descending artery (LAD) and occluded right coronary artery (RCA) (adjusted hazard ratio:
0.99; 95% conﬁdence interval: 0.80 to 1.21; p ¼ 0.91) or between occlusion of the
left circumﬂex artery (CFX) compared with the RCA (adjusted hazard ratio: 1.25;
95% conﬁdence interval: 1.00 to 1.58; p ¼ 0.052). Abbreviation as in Figure 1.
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FIGURE 4 Kaplan-Meier Curve Showing Mortality After Procedures With a
Successfully Revascularized CTO to a Single Vessel
Although opening a major target vessel was associated with reduced mortality (LAD:
hazard ratio: 0.69; 95% conﬁdence interval: 0.49 to 0.97; p ¼ 0.033; CFX: hazard ratio:
0.56; 95% conﬁdence interval: 0.38 to 0.82; p ¼ 0.003; RCA: hazard ratio: 0.73;
95% conﬁdence interval: 0.57 to 0.95; p ¼ 0.017), this was not related to the identity
of the target vessel (interaction p ¼ 0.52). Abbreviations as in Figures 1 and 3.
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242administered following their CTO procedures. Our
database does not include information on specialist
CTO techniques, such as retrograde approaches.
Finally and most importantly, because the groups
were not randomized into treatment strategies, no
formal conclusions about cause and effect can be
drawn.
CONCLUSIONS
Although causation cannot be implied, successful
intervention on a CTO was associated with improved
long-term survival. This improvement was greatest
in patients with complete revascularization. There
is no evidence that the location of the occluded
vessel was associated with differences in mortality
outcomes. Patients may have much to gain from
CTO PCI.
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gmail.com.PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
CTO lesions are present in the coronary arteries of
a substantial minority of patients undergoing
cardiac catheterization. Treatment of CTO lesions
is associated with lower rates of morbidity and
mortality compared with interventions in nonocclu-
sive lesions.
COMPETENCY IN INTERPERSONALAND
COMMUNICATION SKILLS: In managing patients
with CTO lesions, it is important to consider and
discuss all treatment options, including medical
therapy, percutaneous intervention, and coronary
bypass surgery.
TRANSLATIONAL OUTLOOK: The mortality
beneﬁt associated with percutaneous revasculariza-
tion of CTO lesions in this registry study requires
conﬁrmation in randomized trials comparing catheter-
based intervention plus medical therapy versus med-
ical therapy alone to deﬁne the optimum strategy and
identify patients who will gain the most from
revascularization.
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